Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 655.
Congressional Research Service
Official summary
Version 00 · Introduced in House · Jun 15, 2000
Medicare Rx 2000 Act - Title I: Medicare Prescription Drug Benefit - Amends title XVIII (Medicare) of the Social Security Act (SSA) to add a new part D (Voluntary Prescription Drug Benefit Program) to entitle each individual enrolled under Medicare part B (Supplementary Medical Insurance) to obtain qualified prescription drug coverage as outlined. Sets forth general election procedures.(Sec. 101) Prohibits an individual eligible to elect qualified prescription drug coverage under a prescription drug plan or under a Medicare+Choice (Medicare part C) plan from being denied enrollment based on any health status-related factor under the Public Health Service Act or under any other factor.Extends the same prohibition to the case of an individual who maintains continuous prescription drug coverage since first qualifying to elect it, and includes any limitation or conditioning of coverage, or any increased premium based on any such health status-related factor.Allows a prescription drug plan (PDP) sponsor or Medicare+Choice organization, in the case of an individual who does not maintain such continuous prescription drug coverage, to increase the otherwise applicable premium, or to impose a pre-existing condition exclusion, with respect to qualified prescription drug coverage in a manner that reflects additional actuarial risk involved.Sets forth requirements for qualified prescription drug coverage, standard coverage, and alternative coverage.Outlines requirements for access to negotiated prices, actuarial valuation and determination of annual percentage increases, and protections for individuals eligible to enroll under a qualified PDP, such as guaranteed issue and nondiscrimination.Sets out requirements for PDP sponsors as well as financial solvency and capital adequacy standards for non-licensed PDP sponsors. Directs the Medicare Benefits Administrator by regulation to establish other standards for PDP sponsors and plans.Directs the Medicare Benefits Administrator to: (1) establish a process for the selection of the prescription drug plan or Medicare+Choice plan which offers qualified prescription drug coverage; and (2) assure that each individual enrolled under part B has available a choice of enrollment in at least two qualifying plans in the area in which the individual resides, at least one of which is a prescription drug plan.Outlines premium requirements, including those governing submission of premium-related information to the Medicare Benefits Administrator for approval or disapproval, premium rates in the same service area, terms and conditions for imposing premiums, and premium and cost-sharing subsidies for low-income individuals and for Medicare beneficiaries. Creates within the Federal Supplementary Medical Insurance Trust Fund under Medicare part B (Supplementary Medical Insurance) the Medicare Prescription Drug Account for subsidy-related and other payments under new part D. Authorizes appropriations.(Sec. 102) Amends SSA title XVIII part C to provide for prescription drug benefits by Medicare+Choice organizations, including premium and cost-sharing subsidies for low-income enrollees, and reinsurance subsidy payments for Medicare+Choice organizations.(Sec. 103) Amends SSA title XIX (Medicaid) to: (1) require State Medicaid plans to provide for making eligibility determinations for premium and cost-sharing subsidies with regard to the Medicare prescription drug benefit for low-income Medicare beneficiaries; (2) provide for phased-in Federal assumption of Medicaid prescription drug costs for dually-eligible Medicare and Medicaid beneficiaries; (3) require continued Medicaid payment for such an individual to the extent payment is not made under the PDP or the Medicare+Choice plan selected by the individual; and (5) provide for Medicaid prescription drug coverage by territories.(Sec. 104) Prescribes conditions and limitations for prescription drug coverage by new Medicare supplemental (Medigap) policies.Title II: Modernization of Administration of Medicare - Subtitle A: Medicare Benefits Administration - Amends SSA title XVIII to establish within the Department of Health and Human Services the Medicare Benefits Administration, headed by an Administrator charged with carrying out Medicare parts C and D. (Sec. 201) Directs the Secretary to establish within the Medicare Benefits Administration an Office of Beneficiary Assistance to carry out functions relating to Medicare beneficiaries, including benefit eligibility determinations and dissemination of information on benefits and appeals rights.Establishes within the Office a Medicare Ombudsman to: (1) receive complaints, grievances, and requests for information submitted by a Medicare beneficiary concerning any aspect of the Medicare program; (2) provide assistance with respect to such complaints, grievances, and requests; and (3) coordinate with State medical Ombudsman programs, and with State and community-based consumer organizations, to provide information and conduct outreach to educate Medicare beneficiaries with respect to the manner for resolving or avoiding Medicare problems.Establishes within the Medicare Benefits Administration the Medicare Policy Advisory Board.Authorizes appropriations.Subtitle B: Oversight of Financial Sustainability of the Medicare Program - Amends SSA title XVIII part A (Hospital Insurance) with regard to the Federal Hospital Insurance Trust Fund to require its Board of Trustees to report to Congress on the operation and status of such Trust Fund and the Federal Supplementary Medical Insurance Trust Fund, including the total amounts obligated during the preceding fiscal year from the General Revenues of the Treasury to the Trust Funds for Medicare payments and ten-year and 50-year projections of such required benefit obligations.(Sec. 211) Expresses the sense of Congress that the committees of jurisdiction shall hold hearings on such reports.Subtitle C: Changes in Medicare Coverage and Appeals Process - Amends Medicare part D to revise the Medicare appeals process with respect to: (1) a time limit for appeals; (2) expedited reconsideration of an initial determination; (3) local coverage determinations; (4) Internet publication of hearing decisions by the Secretary; and (5) conduct of reconsiderations by independent contractors.(Sec. 222) Limits the liability of an individual for repayment of claims incorrectly paid by the Secretary. Prescribes a procedure for waiver of such liability protection and the individual's right to an appeal. Requires inclusion in the explanation of Medicare benefits of beneficiary liability information, including a specified toll-free telephone number.(Sec. 223) Amends SSA title XI with respect to civil money penalties for improperly filed claims, including offers or transfers of remuneration to influence a beneficiary's choice of provider, practitioner, or item or service supplier. Revises the exclusion from the meaning of remuneration of any waiver of coinsurance and deductible amounts to: (1) make the current conditions for such an exclusion alternative instead of collectively necessary; and (2) add as a new alternative condition for exclusion that such a waiver is offered as a part of a supplemental insurance policy or retiree health plan.(Sec. 224) Amends SSA title D to repeal the Secretary's authority to review, reverse, affirm, or modify decisions of the Provider Reimbursement Review Board.Title III: Medicare+Choice Reforms; Preservation of Medicare Part B Drug Benefit - Subtitle A: Medicare+Choice Reforms - Amends Medicare part C with respect to Federal payments to Medicare+Choice organizations to: (1) reduce the national per capita Medicare+Choice growth percentages for 2001 and 2002; (2) remove application of the budget neutrality factor beginning in 2002 with respect to calculation of both the blended and the national standardized annual Medicare+Choice capitation rates; (3) specify $450 as the minimum payment amount for 2002; (4) allow a Medicare+Choice organization to elect to apply an area-specific percentage of 50 percent and a national percentage of 50 percent for 2002 (currently, only after 2002); (5) increase from 102 percent to 102.5 percent the minimum percentage increase for Medicare+Choice payment areas with only one, or no, Medicare+Choice contracts entered into as of July 1 before the beginning of the year during 2002 through 2005; (6) permit higher annual rates through negotiation between an Medicare+Choice organization and the Medicare Benefits Administration for each year beginning with 2004 in Medicare+Choice payment areas for which the Medicare+Choice capitation rate would otherwise be less than the U.S. per capita cost; and (7) phase-in over a ten-year period beginning in 2004 a risk adjustment methodology based on data from all settings.Subtitle B: Preservation of Medicare Coverage of Drugs and Biologicals - Amends SSA title XVIII part D (Miscellaneous Provisions) with regard to coverage of drugs and biologicals under Medicare part B to modify the specification of drugs and biologicals which cannot be self-administered to drugs and biologicals which are not usually self-administered by the patient.
Mr. Thomas moved to table the motion to appeal the ruling of the chair
Mr. Stark appealed the ruling of the chair. The question was then put on sustaining the ruling of the chair.
Mr. Thomas raised a point of order against the motion to recommit with instructions. Mr. Thomas (CA) stated that the amendment proposed in the motion violated section 302(f) of the Budget Act and exceeded the Committee on Ways and Means allocation of new Budget Authority. Sustained by the Chair. (consideration: CR H5371)
Agreed to dispense with the reading of the motion to recommit.
The Clerk is reading the motion to recommit with instructions.
The Clerk is reading the motion to recommit with instructions.
POINT OF ORDER RESERVED - Mr. Thomas (CA) has reserved all points of order against the motion to recommit with instructions.
Mr. Stark moved to recommit with instructions to Ways and Means. (consideration: CR H5383-5396; text: CR H5383-5396)
The previous question was ordered pursuant to the rule.
DEBATE - The House has resumed debate on H.R. 4680.
USE OF EXHIBIT IN THE CHAMBER - Mr. Weygand (RI) objected to the use of an exhibit in the House Chamber by Ms. Hooley (OR). The Chair put the question on agreeing to the use of the exhibit by voice vote and announced that the noes had prevailed. Subsequently, Mr. Weygand requested a recorded vote.
USE OF EXHIBIT IN THE CHAMBER - Mr. Weygand (RI) objected to the use of an exhibit in the House Chamber by Mr. Olver (MA). The Chair put the question on agreeing to the use of the exhibit by voice vote and announced that the ayes had prevailed. Mr. Weygand subsequently requested a recorded vote.
USE OF EXHIBIT IN THE CHAMBER - Mr. Weygand (RI) objected to the use of an exhibit in the House Chamber by Mr. Menendez (NJ). The Chair put the question on agreeing to the use of the exhibit by voice vote and announced that the ayes had prevailed. Mr. Weygand objected to the voice vote pending the absence of a quorum.
DEBATE - The House proceeded with two hours of debate on H.R. 4680.
Rule provides for consideration of H.R. 4680 with 2 hours of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions.
Considered under the provisions of rule H. Res. 539. (consideration: CR H5319-5415)
Rule H. Res. 539 passed House.
Rules Committee Resolution H. Res. 539 Reported to House. Rule provides for consideration of H.R. 4680 with 2 hours of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions.
Placed on the Union Calendar, Calendar No. 396.
Committee on Commerce discharged.
Committee on Commerce discharged.
House Committee on Commerce Granted an extension for further consideration ending not later than June 27, 2000.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 106-703, Part I.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 106-703, Part I.
Ordered to be Reported (Amended) by the Yeas and Nays: 23 - 14.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health and Environment.
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Primary sources
Bill text & related measures
Text links open the official source. We currently store references to these documents.
Source last updated: Jun 3, 2026. Consult Congress.gov for the current record.
AI Conversation Starters
Explore the bill from different angles
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Neutral evidence review
Objective
Analyze H.R.4680 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
View full prompt & sources
Fairness and public impact
Progressive lens
Examine H.R.4680 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
View full prompt & sources
Institutions and government scope
Conservative lens
Examine H.R.4680 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
View full prompt & sources
Individual rights and government power
Liberty lens
Examine H.R.4680 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.